137 related articles for article (PubMed ID: 11079158)
1. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
Vakharia D; Mizejewski GJ
Breast Cancer Res Treat; 2000 Sep; 63(1):41-52. PubMed ID: 11079158
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment.
Mizejewski GJ; Dias JA; Hauer CR; Henrikson KP; Gierthy J
Mol Cell Endocrinol; 1996 Apr; 118(1-2):15-23. PubMed ID: 8735587
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Jacobson HI; Bennett JA; Mizejewski GJ
Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
[TBL] [Abstract][Full Text] [Related]
5. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens.
Mizejewski GJ; Vonnegut M; Jacobson HI
Proc Natl Acad Sci U S A; 1983 May; 80(9):2733-7. PubMed ID: 6189129
[TBL] [Abstract][Full Text] [Related]
6. A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
Bennett JA; Mesfin FB; Andersen TT; Gierthy JF; Jacobson HI
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2211-5. PubMed ID: 11830647
[TBL] [Abstract][Full Text] [Related]
7. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
[TBL] [Abstract][Full Text] [Related]
10. Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth.
Bennett JA; Semeniuk DJ; Jacobson HI; Murgita RA
Breast Cancer Res Treat; 1997 Sep; 45(2):169-79. PubMed ID: 9342442
[TBL] [Abstract][Full Text] [Related]
11. Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk.
Jacobson HI; Lemanski N; Narendran A; Agarwal A; Bennett JA; Andersen TT
Adv Exp Med Biol; 2008; 617():477-84. PubMed ID: 18497072
[TBL] [Abstract][Full Text] [Related]
12. Separation of the estrogen-activated growth-regulatory forms of alpha-fetoprotein in mouse amniotic fluid.
Mizejewski GJ; Keenan JF; Setty RP
Biol Reprod; 1990; 42(5-6):887-98. PubMed ID: 1696509
[TBL] [Abstract][Full Text] [Related]
13. Effects of rat alpha-fetoprotein administration on estradiol free fraction, the onset of puberty, and neural and uterine nuclear estrogen receptors.
Greenstein BD
Endocrinology; 1992 Jun; 130(6):3184-90. PubMed ID: 1375894
[TBL] [Abstract][Full Text] [Related]
14. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
16. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
17. Purified human alpha fetoprotein inhibits growth factor-stimulated estradiol production by porcine granulosa cells in monolayer culture.
Keel BA; Eddy KB; Cho S; Gangrade BK; May JV
Endocrinology; 1992 Jun; 130(6):3715-7. PubMed ID: 1375908
[TBL] [Abstract][Full Text] [Related]
18. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
19. Specific cytoplasmic alpha-fetoprotein binding protein in MCF-7 human breast cancer cells and primary breast cancer tissue.
Biddle W; Sarcione EJ
Breast Cancer Res Treat; 1987 Dec; 10(3):279-86. PubMed ID: 2451952
[TBL] [Abstract][Full Text] [Related]
20. Studies of the intrinsic antiuterotropic activity of murine alpha-fetoprotein.
Mizejewski GJ; Vonnegut M; Jacobson HI
Tumour Biol; 1986; 7(1):19-36. PubMed ID: 2428091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
